Loading clinical trials...

Acupuncture for Post COVID-19 Fatigue | Clinical Trials | Clareo Health

UNKNOWNNA

Acupuncture for Post COVID-19 Fatigue

The Efficacy and Safety of Acupuncture for Post COVID-19 Fatigue: a Randomized Controlled Trial

NCT05749757•Guang'anmen Hospital of China Academy of Chinese Medical Sciences

View on ClinicalTrials.gov

Summary

The aim of the study is to access the efficacy and safety of acupuncture for post COVID-19 fatigue.

Eligibility

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients aged between 18 and 75.
•Confirmed COVID-19 infection in the past four weeks to six months, and a negative RT PCR and/or Antigen-Based Rapid Test at present.
•A main complaint of fatigue emerged newly following COVID-19 infection.
•A score of ≥15 on Chalder Fatigue Scale (CFS, score range 0-33).
•Participating the trial volunteerly and providing written informed consent.

Exclusion Criteria

•Severe anxiety and depression: a score of ≥25 on 17-item Hamilton Rating Scale for Depression (HAMD-17) and/or a score scores \>29 on 14-item Hamilton Rating Scale for Anxiety (HAMA-14).
•Significant cognitive dysfunction or suicidal tendency.
•Usage of anti-anxiety and/or anti-depression treatments over the last three months.
•Previously diagnosed hypothyroidism or chronic fatigue syndrome.
•A complication of serious and poorly controlled underlying diseases.
•Having symptoms indicating emergency or severe conditions.
•Concurrent use of other anti-fatigue agents or treatments at present.
•Impaired walking ability.
•Pregnant and/or lactating or planning to get pregnant in the next 4 months.

Key Dates

Start Date

March 1, 2023

Primary Completion Date

July 31, 2023

Completion Date

December 31, 2023

Last Updated

March 2, 2023

Enrollment

ESTIMATED participants

Conditions

AcupuncturePost COVID-19 ConditionFatigue

Interventions

Acupuncture

DEVICE

Sham Acupuncture

DEVICE

Contacts

Yuanjie Sun

CONTACT

86 18810337542 puzhisun@163.com

A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture for Treating Precocious Puberty

NCT06510764

Precocious PubertyTreatment+2 more

View study

RECRUITINGNA

Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments

NCT06082518

Post COVID-19 ConditionPost-COVID-19 Syndrome+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 2, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Acupuncture for Post COVID-19 Fatigue

Inclusion Criteria

Exclusion Criteria

A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture for Treating Precocious Puberty

Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments

Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis

Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.

Behavioral and Neural Representations of Subjective Effort Cost